ACKR3 and diffuse large B-cell lymphoma: Thus, the lower proliferation and diminished cell viability, as well as the increased sensitivity to antitumor drugs we observed in CXCR7 overexpressing DLBCL cells support the idea that CXCR7 inhibits the cell survival signaling which is activated by CXCR4 expression.